Savings from largely complete restructuring programs and resulting synergies will underpin our improved Group operating performance. Our Biopharma investor update in June will set out details of program part[Phonetic] of the pipeline and key growth drivers, medium-term financial outlooks and capital allo...
Programmes in other countries The Group has also introduced Orange Cards providing discounts on certain GSK prescription medicines for eligible patients in Bulgaria, Lithuania and Ukraine. The nature of the discounts varies between countries and the way in which the healthcare system operates. In ...